Verastem (VSTM) Current Leases (2019 - 2026)
Verastem (VSTM) recorded quarterly Current Leases of $494000.0 in Q1 2026, down 7.66% quarter-over-quarter from $535000.0 in Q4 2025, and down 51.52% on a YoY basis from $1.0 million in Q1 2025.
Verastem (VSTM) Current Leases (2019 - 2026) Analysis & Trends
Verastem's Current Leases history runs 8 years deep, the most recent figure standing at $494000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 51.52% year-over-year to $494000.0; the TTM figure through Mar 2026 stood at $494000.0 (down 51.52% YoY), while the FY2025 annual figure was $535000.0, down 46.23% from the prior year.
- Current Leases was $494000.0 for Q1 2026 at Verastem, down from $535000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q2 2025 to a low of $494000.0 in Q1 2026.
- Historically, Current Leases has averaged $834058.8 across 5 years, with a median of $829000.0 in 2023.
- The sharpest annual moves came in 2022 and 2026: Current Leases climbed 19.38% in 2022, then slumped 51.52% in 2026.
- A 5-year view of Current Leases shows it stood at $794000.0 in 2022, then increased by 18.51% to $941000.0 in 2023, then gained by 5.74% to $995000.0 in 2024, then plunged by 46.23% to $535000.0 in 2025, then fell by 7.66% to $494000.0 in 2026.
- The last three Current Leases figures came in at $494000.0 (Q1 2026), $535000.0 (Q4 2025), and $793000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 793,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 995,000.00 |
| Sep 30, 2024 | 780,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 941,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 865,000.00 |
| Mar 31, 2023 | 829,000.00 |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 761,000.00 |
| Jun 30, 2022 | 728,000.00 |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 667,000.00 |
| Sep 30, 2021 | 638,000.00 |
| Jun 30, 2021 | 610,000.00 |